These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
7. [The inspection by the Danish Medical Products Agency of drug clinical trials]. Jacobsen E; Stilbo I Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822 [TBL] [Abstract][Full Text] [Related]
8. [The role of the Danish Medical Products Agency in clinical trials]. Simonsen AC Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821 [TBL] [Abstract][Full Text] [Related]
9. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry]. Ebi O Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232 [TBL] [Abstract][Full Text] [Related]
10. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
11. GCP data quality for early clinical development. Rock EP; Molloy VJ; Humphrey JS Clin Cancer Res; 2010 Mar; 16(6):1756-63. PubMed ID: 20215550 [TBL] [Abstract][Full Text] [Related]
12. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites. Zon R; Meropol NJ; Catalano RB; Schilsky RL J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967 [TBL] [Abstract][Full Text] [Related]
14. Status of the GCP guidelines in Europe. Geussenhainer S Methods Find Exp Clin Pharmacol; 1993 May; 15(4):223-8. PubMed ID: 8361259 [TBL] [Abstract][Full Text] [Related]
15. Establishing pan-European clinical trials: regulatory compliance and other practical considerations. Grienenberger A J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097 [TBL] [Abstract][Full Text] [Related]
16. Objectives of QC systems and QA function in clinical research. Poy E Qual Assur; 1993 Dec; 2(4):326-31. PubMed ID: 7952966 [TBL] [Abstract][Full Text] [Related]
17. [The role of ethical committees in drug trials performed according to "Good Clinical Practice"]. Kerpel-Fronius S Orv Hetil; 1991 Mar; 132(13):703-5. PubMed ID: 2014128 [TBL] [Abstract][Full Text] [Related]
18. [Quality assurance in clinical studies: a necessity]. Boll M; Binder J; Siegel A; Grundmann R Z Exp Chir Transplant Kunstliche Organe; 1990; 23(2):65-72. PubMed ID: 2278157 [TBL] [Abstract][Full Text] [Related]
19. Stem cell transplantation in children: how to design a new study. Corbacioglu S; Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S30-4. PubMed ID: 18545241 [TBL] [Abstract][Full Text] [Related]
20. The development of good clinical practice in the EEC and in Germany. Anhalt E Methods Find Exp Clin Pharmacol; 1993 May; 15(4):217-22. PubMed ID: 8361258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]